TD Cowen Maintains Buy on Charles River, Raises Price Target to $325
9/25/2026
Impact: 80
Healthcare
TD Cowen analyst Charles Rhyee has maintained a Buy rating on Charles River (NYSE: CRL) and increased the price target from $300 to $325. This adjustment reflects a positive outlook for the company's performance in the market.
AI summary, not financial advice
Share: